MRI Interventions, Inc. is a medical technology company that designs, manufactures and markets systems for minimally invasive neurosurgical procedures under real‐time magnetic resonance imaging (MRI) guidance. The company’s flagship offering, the ClearPoint® Neuro Navigation System, enables physicians to perform precise brain biopsies, targeted drug and cell therapy delivery, deep brain stimulation lead implantation and laser ablation with continuous three‐dimensional MRI visualization.
The ClearPoint System integrates proprietary MRI‐compatible instruments and software modules to streamline intraoperative planning, targeting and confirmation—all within the bore of a standard clinical MRI scanner. By providing direct feedback on needle or cannula placement, the system aims to enhance procedural accuracy, reduce reliance on computed tomography or X‐ray imaging, and ultimately improve patient outcomes in neurosurgical applications.
Since receiving its initial FDA clearance in 2012 and CE Mark in Europe, MRI Interventions has supported centers of excellence in North America and select international markets. The company is headquartered in Memphis, Tennessee, and collaborates with academic medical centers and clinical researchers to expand the use of MRI‐guided interventions for emerging therapies, including gene and cell delivery to the brain.
Led by a management team with deep experience in medical device innovation and regulatory affairs, MRI Interventions focuses on broadening adoption of its technology across neurosurgical specialties. Ongoing product development efforts aim to refine the user interface, expand compatibility with additional MRI platforms and introduce new instrument families to address a wider range of clinical targets.
AI Generated. May Contain Errors.
Free MRIC Stock Alerts